A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA (adalimumab) in Pediatric Patients with Moderately to Severely Active Crohn’s Disease (CD) - CAPE First published 30/04/2014 Last updated 28/01/2026 EU PAS number:EUPAS6213 Study Ongoing